1. Home
  2. FMY vs CELU Comparison

FMY vs CELU Comparison

Compare FMY & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMY
  • CELU
  • Stock Information
  • Founded
  • FMY 2005
  • CELU 2016
  • Country
  • FMY United States
  • CELU United States
  • Employees
  • FMY N/A
  • CELU N/A
  • Industry
  • FMY Finance/Investors Services
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • FMY Finance
  • CELU Health Care
  • Exchange
  • FMY Nasdaq
  • CELU Nasdaq
  • Market Cap
  • FMY 50.9M
  • CELU 50.4M
  • IPO Year
  • FMY N/A
  • CELU N/A
  • Fundamental
  • Price
  • FMY $12.10
  • CELU $1.68
  • Analyst Decision
  • FMY
  • CELU
  • Analyst Count
  • FMY 0
  • CELU 0
  • Target Price
  • FMY N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • FMY 10.1K
  • CELU 182.6K
  • Earning Date
  • FMY 01-01-0001
  • CELU 12-06-2024
  • Dividend Yield
  • FMY 6.98%
  • CELU N/A
  • EPS Growth
  • FMY N/A
  • CELU N/A
  • EPS
  • FMY N/A
  • CELU N/A
  • Revenue
  • FMY N/A
  • CELU $48,200,000.00
  • Revenue This Year
  • FMY N/A
  • CELU N/A
  • Revenue Next Year
  • FMY N/A
  • CELU $233.89
  • P/E Ratio
  • FMY N/A
  • CELU N/A
  • Revenue Growth
  • FMY N/A
  • CELU 225.94
  • 52 Week Low
  • FMY $10.71
  • CELU $1.30
  • 52 Week High
  • FMY $12.17
  • CELU $7.97
  • Technical
  • Relative Strength Index (RSI)
  • FMY 52.99
  • CELU 37.21
  • Support Level
  • FMY $12.01
  • CELU $1.85
  • Resistance Level
  • FMY $12.16
  • CELU $2.18
  • Average True Range (ATR)
  • FMY 0.11
  • CELU 0.26
  • MACD
  • FMY -0.00
  • CELU -0.05
  • Stochastic Oscillator
  • FMY 59.79
  • CELU 5.46

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: